Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Bisacodyl Suppository Considerations

Common Side Effects

  • Diarrhea is a common side effect, with studies showing diarrhea rates of 53.4% in patients using oral bisacodyl (vs 1.7% with placebo) 2
  • Abdominal pain occurs in approximately 24.7% of patients using bisacodyl (vs 2.5% with placebo) 2

Contraindications

  • Bisacodyl suppositories are contraindicated in individuals with ileus or intestinal obstruction 2
  • Bisacodyl suppositories are contraindicated in individuals with severe dehydration 2
  • Bisacodyl suppositories are contraindicated in individuals with acute inflammatory conditions in the bowel 2
  • Bisacodyl suppositories are contraindicated in individuals with recent colorectal or gynecological surgery 3
  • Bisacodyl suppositories are contraindicated in individuals with recent anal or rectal trauma 3

Risks with Long-term Use

  • Prolonged or excessive use can lead to electrolyte imbalances 4
  • The American Gastroenterological Association recommends bisacodyl primarily for short-term use or as rescue therapy rather than for long-term treatment 1

Special Considerations

  • The onset of action for rectal suppositories is typically within 30-60 minutes 2
  • Suppositories may be perceived as more invasive than oral options by many patients 3
  • Antibiotics can potentially decrease the efficacy of bisacodyl as they may affect the gut bacteria involved in metabolizing the drug 7
  • Risk of rectal mucosal damage with improper administration 3
  • Patients on anticoagulation therapy or with coagulation disorders may be at increased risk of bleeding complications 3

Practical Limitations

  • Starting with a lower dose is recommended to minimize side effects, which may require dose titration 1
  • Requires privacy and appropriate positioning for administration, which may be challenging in certain settings 3
  • May not be suitable for patients with limited mobility or dexterity who cannot self-administer 3